CVE-2023-33218

Stack Buffer Overflow in a binary run at upgrade startup

Description

The Parameter Zone Read and Parameter Zone Write command handlers allow performing a Stack buffer overflow. This could potentially lead to a Remote Code execution on the targeted device.

Categories

9.1
CVSS
Severity: Critical
CVSS 3.1 •
EPSS 1.22% Top 25%
Vendor Advisory idemia.com
Affected: IDEMIA SIGMA Lite & Lite +
Affected: IDEMIA SIGMA Wide
Affected: IDEMIA SIGMA Extreme
Affected: IDEMIA MorphoWave Compact/XP
Affected: IDEMIA VisionPass
Affected: IDEMIA MorphoWave SP
Published at:
Updated at:

References

Link Tags
https://www.idemia.com/wp-content/uploads/2023/11/Security-Advisory-SA-2023-05-2.pdf vendor advisory

Frequently Asked Questions

What is the severity of CVE-2023-33218?
CVE-2023-33218 has been scored as a critical severity vulnerability.
How to fix CVE-2023-33218?
To fix CVE-2023-33218, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-33218 being actively exploited in the wild?
It is possible that CVE-2023-33218 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-33218?
CVE-2023-33218 affects IDEMIA SIGMA Lite & Lite +, IDEMIA SIGMA Wide, IDEMIA SIGMA Extreme, IDEMIA MorphoWave Compact/XP, IDEMIA VisionPass, IDEMIA MorphoWave SP.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.